{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:41Z","timestamp":1787041661840,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Independent Research Funding of the General Hospital of Northern Theater Command","award":["ZZKY2024027 and ZZKY2024018"],"award-info":[{"award-number":["ZZKY2024027 and ZZKY2024018"]}]},{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","award":["XLYC2203078"],"award-info":[{"award-number":["XLYC2203078"]}],"id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00228-026-04135-2","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:52:08Z","timestamp":1784609528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proton pump inhibitors for prevention of upper and lower gastrointestinal bleeding in patients taking aspirin: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"82","author":[{"given":"Siqi","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9448-6739","authenticated-orcid":false,"given":"Xingshun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"8","key":"4135_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00535-008-2206-5","volume":"43","author":"A Shiotani","year":"2008","unstructured":"Shiotani A, Kamada T, Haruma K (2008) Low-dose aspirin-induced gastrointestinal diseases: past, present, and future. J Gastroenterol 43(8):581\u2013588","journal-title":"J Gastroenterol"},{"issue":"12","key":"4135_CR2","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/M16-0577","volume":"164","author":"K Bibbins-Domingo","year":"2016","unstructured":"Bibbins-Domingo K, U.S Preventive Services Task Force (2016) Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 164(12):836\u2013845","journal-title":"Ann Intern Med"},{"issue":"4","key":"4135_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1365-2125.2011.03943.x","volume":"72","author":"TD Warner","year":"2011","unstructured":"Warner TD, Nylander S, Whatling C (2011) Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy. Br J Clin Pharmacol 72(4):619\u2013633","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"4135_CR4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cgh.2018.05.061","volume":"17","author":"L Cea Soriano","year":"2019","unstructured":"Cea Soriano L, Lanas A, Soriano-Gabarr\u00f3 M, Garc\u00eda Rodr\u00edguez LA (2019) Incidence of upper and lower gastrointestinal bleeding in new users of low-dose aspirin. Clin Gastroenterol Hepatol 17(5):887\u201395.e6","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"4135_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/07853890.2019.1591635","volume":"51","author":"LA Garc\u00eda Rodr\u00edguez","year":"2019","unstructured":"Garc\u00eda Rodr\u00edguez LA, Lanas A, Soriano-Gabarr\u00f3 M, Cea Soriano L (2019) Low-dose aspirin and risk of upper\/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom. Ann Med 51(2):182\u2013192","journal-title":"Ann Med"},{"issue":"4","key":"4135_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/gutjnl-2020-321585","volume":"70","author":"SE Mahady","year":"2021","unstructured":"Mahady SE, Margolis KL, Chan A et al (2021) Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trial. Gut 70(4):717\u2013724","journal-title":"Gut"},{"issue":"11","key":"4135_CR7","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1046\/j.1365-2036.2002.01355.x","volume":"16","author":"P Serrano","year":"2002","unstructured":"Serrano P, Lanas A, Arroyo MT, Ferreira IJ (2002) Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 16(11):1945\u20131953","journal-title":"Aliment Pharmacol Ther"},{"key":"4135_CR8","doi-asserted-by":"crossref","unstructured":"Masclee GM, Valkhoff VE, Coloma PM et al (2014) Risk of upper gastrointestinal bleeding from different drug combinations. Gastroenterology 147(4):784\u2013792.e9; quiz e13-4.","DOI":"10.1053\/j.gastro.2014.06.007"},{"issue":"6","key":"4135_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s00535-015-1038-3","volume":"50","author":"A Lanas","year":"2015","unstructured":"Lanas A, Gargallo CJ (2015) Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective. J Gastroenterol 50(6):626\u2013637","journal-title":"J Gastroenterol"},{"key":"4135_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev.pa.35.040195.001425","volume":"35","author":"G Sachs","year":"1995","unstructured":"Sachs G, Shin JM, Briving C, Wallmark B, Hersey S (1995) The pharmacology of the gastric acid pump: the H+,K+ ATPase. Annu Rev Pharmacol Toxicol 35:277\u2013305","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"18","key":"4135_CR11","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","volume":"52","author":"DL Bhatt","year":"2008","unstructured":"Bhatt DL, Scheiman J, Abraham NS et al (2008) ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 52(18):1502\u20131517","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4135_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.mayocp.2021.11.037","volume":"97","author":"M Zhou","year":"2022","unstructured":"Zhou M, Zhang J, Liu J et al (2022) Proton Pump Inhibitors and In-Hospital Gastrointestinal Bleeding in Patients With Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy. Mayo Clin Proc 97(4):682\u2013692","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"4135_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.dld.2015.05.020","volume":"47","author":"K Miyake","year":"2015","unstructured":"Miyake K, Akimoto T, Hanada Y et al (2015) Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease. Dig Liver Dis 47(9):757\u2013762","journal-title":"Dig Liver Dis"},{"issue":"9","key":"4135_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ueg2.12448","volume":"11","author":"YS Jung","year":"2023","unstructured":"Jung YS, Park JH, Park CH (2023) Impact of proton pump inhibitors on the risk of small bowel or colorectal bleeding: A systematic review and meta-analysis. United Eur Gastroenterol J 11(9):861\u2013873","journal-title":"United Eur Gastroenterol J"},{"key":"4135_CR15","doi-asserted-by":"crossref","unstructured":"Garc\u00eda Rodr\u00edguez LA, Lanas A, Soriano-Gabarr\u00f3 M, Vora P, Cea Soriano L (2020) Effect of Proton pump inhibitors on risks of upper and lower gastrointestinal bleeding among users of low-dose aspirin: a population-based observational study. J Clin Med 9(4):928","DOI":"10.3390\/jcm9040928"},{"issue":"7","key":"4135_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4292\/wjgpt.v9.i7.63","volume":"9","author":"P Rawla","year":"2018","unstructured":"Rawla P, Sunkara T, Ofosu A, Gaduputi V (2018) Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors? World J Gastrointest Pharmacol Ther 9(7):63\u201368","journal-title":"World J Gastrointest Pharmacol Ther"},{"issue":"12","key":"4135_CR17","first-page":"693","volume":"18","author":"N Wong","year":"2022","unstructured":"Wong N, Reddy A, Patel A (2022) Potassium-Competitive Acid Blockers: Present and Potential Utility in the Armamentarium for Acid Peptic Disorders. Gastroenterol Hepatol (N Y) 18(12):693\u2013700","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"2","key":"4135_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/apt.13876","volume":"45","author":"H Miwa","year":"2017","unstructured":"Miwa H, Uedo N, Watari J et al (2017) Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials. Aliment Pharmacol Ther 45(2):240\u2013252","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"4135_CR19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/gutjnl-2017-314852","volume":"67","author":"T Kawai","year":"2018","unstructured":"Kawai T, Oda K, Funao N et al (2018) Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study. Gut 67(6):1033\u20131041","journal-title":"Gut"},{"issue":"6","key":"4135_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/apt.13325","volume":"42","author":"Y Sakurai","year":"2015","unstructured":"Sakurai Y, Mori Y, Okamoto H et al (2015) Acid-inhibitory effects of vonoprazan 20\u00a0mg compared with esomeprazole 20\u00a0mg or rabeprazole 10\u00a0mg in healthy adult male subjects\u2013a randomised open-label cross-over study. Aliment Pharmacol Ther 42(6):719\u2013730","journal-title":"Aliment Pharmacol Ther"},{"key":"4135_CR21","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"issue":"5","key":"4135_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","volume":"64","author":"JL Brozek","year":"2009","unstructured":"Brozek JL, Akl EA, Alonso-Coello P et al (2009) Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 64(5):669\u2013677","journal-title":"Allergy"},{"issue":"26","key":"4135_CR23","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1056\/NEJMoa012877","volume":"346","author":"KC Lai","year":"2002","unstructured":"Lai KC, Lam SK, Chu KM et al (2002) Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 346(26):2033\u20132038","journal-title":"N Engl J Med"},{"issue":"6","key":"4135_CR24","first-page":"856","volume":"124","author":"YH Ren","year":"2011","unstructured":"Ren YH, Zhao M, Chen YD et al (2011) Omeprazole affects clopidogrel efficacy but not ischemic events in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention. Chin Med J (Engl) 124(6):856\u2013861","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"4135_CR25","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s00535-012-0588-x","volume":"47","author":"T Sanuki","year":"2012","unstructured":"Sanuki T, Fujita T, Kutsumi H et al (2012) Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial. J Gastroenterol 47(11):1186\u20131197","journal-title":"J Gastroenterol"},{"issue":"11","key":"4135_CR26","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1253\/circj.CJ-12-0511","volume":"76","author":"H Yano","year":"2012","unstructured":"Yano H, Tsukahara K, Morita S et al (2012) Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study. Circ J 76(11):2673\u20132680","journal-title":"Circ J"},{"issue":"6","key":"4135_CR27","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00535-011-0397-7","volume":"46","author":"K Sugano","year":"2011","unstructured":"Sugano K, Matsumoto Y, Itabashi T et al (2011) Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. J Gastroenterol 46(6):724\u2013735","journal-title":"J Gastroenterol"},{"issue":"1","key":"4135_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.gastro.2009.09.063","volume":"138","author":"FH Ng","year":"2010","unstructured":"Ng FH, Wong SY, Lam KF et al (2010) Famotidine Is Inferior to Pantoprazole in Preventing Recurrence of Aspirin-Related Peptic Ulcers or Erosions. Gastroenterology 138(1):82\u201388","journal-title":"Gastroenterology"},{"issue":"10","key":"4135_CR29","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1111\/j.1572-0241.2008.01995.x","volume":"103","author":"N Yeomans","year":"2008","unstructured":"Yeomans N, Lanas A, Labenz J et al (2008) Efficacy of esomeprazole (20\u00a0mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroenterol 103(10):2465\u20132473","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"4135_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/ajg.2011.385","volume":"107","author":"FH Ng","year":"2012","unstructured":"Ng FH, Tunggal P, Chu WM et al (2012) Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction. Am J Gastroenterol 107(3):389\u2013396","journal-title":"Am J Gastroenterol"},{"issue":"20","key":"4135_CR31","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","volume":"363","author":"DL Bhatt","year":"2010","unstructured":"Bhatt DL, Cryer BL, Contant CF et al (2010) Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 363(20):1909\u20131917","journal-title":"N Engl J Med"},{"issue":"1","key":"4135_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/j.gastro.2016.09.006","volume":"52","author":"FK Chan","year":"2017","unstructured":"Chan FK, Kyaw M, Tanigawa T et al (2017) Similar efficacy of proton-pump inhibitors vs H2-receptor antagonists in reducing risk of upper gastrointestinal bleeding or ulcers in high-risk users of low-dose aspirin. Gastroenterology 152(1):105\u201310.e1","journal-title":"Gastroenterology"},{"issue":"7","key":"4135_CR33","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/apt.12907","volume":"40","author":"R Iwakiri","year":"2014","unstructured":"Iwakiri R, Higuchi K, Kato M et al (2014) Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin. Aliment Pharmacol Ther 40(7):780\u2013795","journal-title":"Aliment Pharmacol Ther"},{"key":"4135_CR34","doi-asserted-by":"crossref","unstructured":"Jia RJ, Wang XP, Zhang ZH et al (2022) Effect of rabeprazole and rebamipide in the treatment of upper gastrointestinal hemorrhage associated with dual antiplatelet therapy in elderly patients with coronary heart disease. Clin Appl Thromb Hemost 28:10760296221130746","DOI":"10.1177\/10760296221130746"},{"issue":"1","key":"4135_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/JCMA.0000000000000465","volume":"84","author":"ZF Tseng","year":"2021","unstructured":"Tseng ZF, Hsu PI, Peng NJ et al (2021) Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: a randomized controlled trial. J Chin Med Assoc 84(1):19\u201324","journal-title":"J Chin Med Assoc"},{"issue":"5","key":"4135_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.hjc.2019.06.001","volume":"61","author":"F Zhang","year":"2020","unstructured":"Zhang F, Su S, Hou Y et al (2020) Effects (MACE and bleeding events) of ticagrelor combined with omeprazole on patients with acute myocardial infarction undergoing primary PCI. Hellenic J Cardiol 61(5):306\u2013310","journal-title":"Hellenic J Cardiol"},{"issue":"14","key":"4135_CR37","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.jacc.2015.12.068","volume":"67","author":"M Vaduganathan","year":"2016","unstructured":"Vaduganathan M, Bhatt DL, Cryer BL et al (2016) Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy. J Am Coll Cardiol 67(14):1661\u20131671","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4135_CR38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/cts.13165","volume":"15","author":"P Wei","year":"2022","unstructured":"Wei P, Zhuo S, Fu Q et al (2022) The efficacy and safety of the short-term combination therapy with ticagrelor and PPIs or H2RA in patients with acute STEMI who underwent emergency PCI. Clin Transl Sci 15(2):477\u2013489","journal-title":"Clin Transl Sci"},{"issue":"11","key":"4135_CR39","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2169\/internalmedicine.53.2159","volume":"53","author":"Y Sakamoto","year":"2014","unstructured":"Sakamoto Y, Shimoyama T, Nakagawa S, Mikami T, Fukuda S (2014) Proton pump inhibitor treatment decreases the incidence of upper gastrointestinal disorders in elderly Japanese patients treated with NSAIDs. Intern Med 53(11):1107\u20131111","journal-title":"Intern Med"},{"issue":"2","key":"4135_CR40","first-page":"245","volume":"83","author":"B Tang","year":"2020","unstructured":"Tang B, Xiao S (2020) Logistic regression analysis of risk factors for upper gastrointestinal bleeding induced by PCI in combination with double antiplatelet therapy for STEMI patients. Acta Gastroenterol Belg 83(2):245\u2013248","journal-title":"Acta Gastroenterol Belg"},{"issue":"3\u20134","key":"4135_CR41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000141264","volume":"77","author":"FH Ng","year":"2008","unstructured":"Ng FH, Lam KF, Wong SY et al (2008) Upper gastrointestinal bleeding in patients with aspirin and clopidogrel co-therapy. Digestion 77(3\u20134):173\u2013177","journal-title":"Digestion"},{"issue":"2","key":"4135_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2036.2006.02759.x","volume":"23","author":"L Ib\u00e1\u00f1ez","year":"2006","unstructured":"Ib\u00e1\u00f1ez L, Vidal X, Vendrell L, Moretti U, Laporte JR (2006) Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment Pharmacol Ther 23(2):235\u2013242","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"4135_CR43","doi-asserted-by":"publisher","first-page":"e035239","DOI":"10.1161\/JAHA.124.035239","volume":"14","author":"M Baik","year":"2025","unstructured":"Baik M, Jeon J, Heo SJ, Kim J, Yoo J (2024 ) Proton Pump Inhibitors Use in Patients With Ischemic Stroke on Dual Antiplatelet Therapy at Low Risk of Upper Gastrointestinal Bleeding. J Am Heart Assoc 14(1):e035239","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"4135_CR44","first-page":"1142","volume":"14","author":"M Baik","year":"2024","unstructured":"Baik M, Jeon J, Kim J, Yoo J (2024) Proton Pump Inhibitor for Gastrointestinal Bleeding in Patients with Myocardial Infarction on Dual-Antiplatelet Therapy: A Nationwide Cohort Study. Korean J Intern Med 14(3):1142\u20131151","journal-title":"Korean J Intern Med"},{"issue":"7","key":"4135_CR45","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/jgh.16989","volume":"40","author":"M Baik","year":"2025","unstructured":"Baik M, Jeon J, Yoo J, Kim J (2025) Effect of Potassium-Competitive Acid Blockers on Upper Gastrointestinal Bleeding in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study. J Gastroenterol Hepatol 40(7):1686\u20131694","journal-title":"J Gastroenterol Hepatol"},{"key":"4135_CR46","doi-asserted-by":"publisher","first-page":"693567","DOI":"10.1155\/2014\/693567","volume":"2014","author":"WC Chen","year":"2014","unstructured":"Chen WC, Li YD, Chiang PH et al (2014) Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers\/erosions in long-term low-dose aspirin users: a retrospective cohort study. Biomed Res Int 2014:693567","journal-title":"Biomed Res Int"},{"issue":"1","key":"4135_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jjcc.2020.02.012","volume":"76","author":"K Tsujita","year":"2020","unstructured":"Tsujita K, Deguchi H, Uda A, Sugano K (2020) Upper gastrointestinal bleeding in Japanese patients with ischemic heart disease receiving vonoprazan or a proton pump inhibitor with multiple antithrombotic agents: A nationwide database study. J Cardiol 76(1):51\u201357","journal-title":"J Cardiol"},{"issue":"4","key":"4135_CR48","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3904\/kjim.2022.340","volume":"38","author":"HS Lee","year":"2023","unstructured":"Lee HS, Nam JH, Oh DJ, Ahn HJ, Lim YJ (2023) Association between eupatilin and reduction in small bowel bleeding in aspirin users and aspirin plus acid suppressant users. Korean J Intern Med 38(4):484\u2013492","journal-title":"Korean J Intern Med"},{"issue":"5","key":"4135_CR49","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.gie.2014.03.024","volume":"80","author":"H Endo","year":"2014","unstructured":"Endo H, Sakai E, Taniguchi L et al (2014) Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: data from a prospective multicenter capsule endoscopy registry. Gastrointest Endosc 80(5):826\u2013834","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"4135_CR50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10557-025-07702-4","volume":"40","author":"MY Lee","year":"2026","unstructured":"Lee MY, Heo KN, Shin J, Lee JY (2026) A Novel Approach to Gastrointestinal Bleeding Risk Stratification and Proton Pump Inhibitor Effectiveness in Patients with Acute Coronary Syndrome on Dual Antiplatelet Therapy: A Nationwide Retrospective Cohort Study. Cardiovasc Drugs Ther 40(1):263\u2013276","journal-title":"Cardiovasc Drugs Ther"},{"issue":"10","key":"4135_CR51","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/ijcp.12634","volume":"69","author":"A Tran-Duy","year":"2015","unstructured":"Tran-Duy A, Vanmolkot FH, Joore MA, Hoes AW, Stehouwer CD (2015) Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis. Int J Clin Pract 69(10):1088\u20131111","journal-title":"Int J Clin Pract"},{"issue":"4","key":"4135_CR52","doi-asserted-by":"publisher","first-page":"395","DOI":"10.15403\/jgld.2014.1121.264.hra","volume":"26","author":"IL Szab\u00f3","year":"2017","unstructured":"Szab\u00f3 IL, M\u00e1tics R, Hegyi P et al (2017) PPIs Prevent Aspirin-Induced Gastrointestinal Bleeding Better than H2RAs. A Systematic Review and Meta-analysis. J Gastrointestin Liver Dis 26(4):395\u2013402","journal-title":"J Gastrointestin Liver Dis"},{"issue":"3","key":"4135_CR53","doi-asserted-by":"publisher","first-page":"e9638","DOI":"10.1097\/MD.0000000000009638","volume":"97","author":"W Hu","year":"2018","unstructured":"Hu W, Tong J, Kuang X, Chen W, Liu Z (2018) Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrel: A meta-analysis. Medicine (Baltimore) 97(3):e9638","journal-title":"Med (Baltim)"},{"issue":"17","key":"4135_CR54","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.3748\/wjg.v21.i17.5382","volume":"21","author":"C Mo","year":"2015","unstructured":"Mo C, Sun G, Lu ML et al (2015) Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries. World J Gastroenterol 21(17):5382\u20135392","journal-title":"World J Gastroenterol"},{"issue":"4 Suppl 2","key":"4135_CR55","first-page":"6","volume":"19","author":"DL Earnest","year":"1990","unstructured":"Earnest DL (1990) NSAID-induced gastric injury: its pathogenesis and management. Semin Arthritis Rheum 19(4 Suppl 2):6\u201310","journal-title":"Semin Arthritis Rheum"},{"issue":"6 Suppl","key":"4135_CR56","doi-asserted-by":"publisher","first-page":"S356","DOI":"10.1097\/00003246-200206001-00003","volume":"30","author":"JR Pisegna","year":"2002","unstructured":"Pisegna JR (2002) Pharmacology of acid suppression in the hospital setting: focus on proton pump inhibition. Crit Care Med 30(6 Suppl):S356\u2013S361","journal-title":"Crit Care Med"},{"issue":"4","key":"4135_CR57","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1006\/phrs.1998.0448","volume":"39","author":"K Nishida","year":"1999","unstructured":"Nishida K, Ohta Y, Ishiguro I (1999) Preventive effect of teprenone on stress-induced gastric mucosal lesions and its relation to gastric mucosal constitutive nitric oxide synthase activity. Pharmacol Res 39(4):325\u2013332","journal-title":"Pharmacol Res"},{"issue":"25","key":"4135_CR58","doi-asserted-by":"publisher","first-page":"7800","DOI":"10.1021\/ja049607w","volume":"126","author":"JM Shin","year":"2004","unstructured":"Shin JM, Cho YM, Sachs G (2004) Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J Am Chem Soc 126(25):7800\u20137811","journal-title":"J Am Chem Soc"},{"key":"4135_CR59","doi-asserted-by":"publisher","first-page":"6069151","DOI":"10.1155\/2024\/6069151","volume":"2024","author":"NR Lim","year":"2024","unstructured":"Lim NR, Lim S, Chung WC (2024) A Study on the glucose breath test positivity rate and occurrence of small intestine bacterial overgrowth-related symptoms caused by long-term use of Proton Pump Inhibitor (PPI) versus Potassium-Competitive Acid Blocker (P-CAB) in elderly patients: SIBO Between PPI and P-CAB. Adv Pharmacol Pharm Sci 2024:6069151","journal-title":"Adv Pharmacol Pharm Sci"},{"key":"4135_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.coph.2014.05.008","volume":"19","author":"RW Blackler","year":"2014","unstructured":"Blackler RW, Gemici B, Manko A, Wallace JL (2014) NSAID-gastroenteropathy: new aspects of pathogenesis and prevention. Curr Opin Pharmacol 19:11\u201316","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"4135_CR61","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrgastro.2012.57","volume":"9","author":"E Deloose","year":"2012","unstructured":"Deloose E, Janssen P, Depoortere I, Tack J (2012) The migrating motor complex: control mechanisms and its role in health and disease. Nat Rev Gastroenterol Hepatol 9(5):271\u2013285","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"4135_CR62","doi-asserted-by":"publisher","first-page":"G228","DOI":"10.1152\/ajpgi.00212.2015","volume":"310","author":"E Deloose","year":"2016","unstructured":"Deloose E, Tack J (2016) Redefining the functional roles of the gastrointestinal migrating motor complex and motilin in small bacterial overgrowth and hunger signaling. Am J Physiol Gastrointest Liver Physiol 310(4):G228\u2013G233","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04135-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04135-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04135-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:02:59Z","timestamp":1787040179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04135-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4135"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04135-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The abstract of this meta-analysis was presented as an oral poster at the 25th Annual Meeting of the Chinese Medical Association on Gastroenterology in Changsha, China, on October 25, 2025.","order":2,"name":"Ethics","label":"Previous presentation","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"212"}}